Chicago-based GE HealthCare is set to acquire Intelerad, a medical imaging software company with a strong outpatient and ambulatory presence, for $2.3 billion in cash.
The deal will expand GE HealthCare’s enterprise imaging footprint beyond hospitals and academic centers into high-growth outpatient and teleradiology markets. Intelerad’s cloud-based platform, which supports radiology and cardiology workflows, will be integrated with GE HealthCare’s existing AI and imaging portfolio, according to a Nov. 20 GE news release.
GE HealthCare said it aims to triple its cloud-enabled product offerings by 2028 and sees the acquisition as a step toward growing recurring software-as-a-service, or SaaS, revenue. Intelerad generates about $270 million in annual revenue, with roughly 90% recurring, and a reported EBITDA margin above 30%.
The deal is expected to close in the first half of 2026, pending regulatory approvals, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
